The Journal of mHealth today announced their annual Global Digital Health 100 recognising the most innovative health technology companies from around the world. This is Activ8rlives’ fifth time to have been included on the list.
Now in its sixth year, the annual Global Digital Health 100 is one of HealthTech industry’s foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered.
Dr Kevin Auton, Managing Director of medical device innovator Aseptika (Activ8rlives), commented
“We are delighted to have received this accolade again this year.
Our most recent digital health initiative, Asthma⁺me, increases the knowledge and confidence of families with children that have moderate-to-severe asthma to self-manage. Improving skills, building expertise and having tools to forewarn of an asthma attack, all leading to better health outcomes, fewer hospital admissions and outpatient clinics means more time for children to attend school.
Current development and integration of AI components during the RCT will significantly enhance the solution allowing disease status reporting to the specialist clinic, less clinician time and in-built expertise for patients and parents. The Asthma⁺me App is the first remote monitoring self-management solution in paediatric clinical trials, that allows risk stratification on need, a personalised-care approach, thereby reducing emergency admissions, improving patient safety and quality-of-life.”
You can view the full list of winners here: www.thejournalofmhealth.com/digital-health-100
Further information:
For further details, please contact Jessica Auton on +44 (0)1480 352 821 or email jessica.auton@aseptika.com
The Journal of mHealth www.thejournalofmhealth.com
The Journal of mHealth is the “Voice of the HealthTech Industry“. A trusted resource for anyone with an interest in innovative and emerging health technologies, technology-enabled healthcare, medical devices, and digital health services, the Journal has a European audience of over 20,000.
The Journal of mHealth is a leading international publication bringing the latest developments in innovative emerging health technologies to healthcare and industry professionals around the world. Featuring, the Latest Industry News, Articles, Research, Industry Whitepapers and Market Reports.
The Global Digital Health 100
The Journal of mHealth organise the acclaimed annual Global Digital Health 100 power-list recognising the most innovative companies working in the HealthTech industry. If you want to know which companies are succeeding, and why, along with the latest technology trends in health technology then visit www.thejournalofmhealth.com/digital-health-100
The diversity of this year’s list stands out immediately, with new entrants from all sides of the technology spectrum, targeting just about every corner of healthcare. The honouree companies offer technologies across a range of categories including; clinical solutions, wearable technologies, healthcare applications, medical devices, virtual reality and data analytics. These are all solutions and services that are transforming, or have the potential to transform, and disrupt the way in which healthcare is delivered.
The Global Digital Health 100 recognises and celebrates the companies and technology leaders within the industry that are raising the bar and shaping the future of healthcare delivery. We are proud to support the growth and success of this thriving technology industry which is being led by the honourees of these awards.
As a leading publication in Europe and North America The Journal of mHealth gains a unique perspective from our relationship with emerging health technology markets around the World. This enables us to bring one of the most comprehensive lists of technology providers who are representative of the latest technology trends from across the healthcare industry.
The Global Digital Health 100 represents months of analysis by the editorial and advisory team at The Journal of mHealth, who considered the offerings and innovations from companies across the HealthTech ecosystem.
The judging criteria analysed 10 different quantitative and qualitative evaluation metrics including: disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and, industry integration. The selected 100 companies demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria ensure that companies are considered truly upon innovation, allowing start-up offerings to be compared alongside established and larger organisations.